Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Graf

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer typesDavid R Gandara, Neeraj Agarwal, Shilpa Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance MechanismsHanna Tukachinsky, Russell W Madison, Jon H Chung, et al.
The Journal of Molecular Diagnostics : JMD|August 22, 2025
High-Specificity Detection of UV Mutational Signatures in Circulating Tumor DNA for Diagnostic Classification of Cutaneous and Unknown Primary Tumors Using FoundationOne Liquid CDxDouglas A Mata, Angela A Kou, Andreas M Heilmann, et al.
Oncotarget|July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerKarim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted TherapiesM Aldea, S Lenahan, M-A Locquet, et al.
Archives of Physical Medicine and Rehabilitation|May 21, 2023
The American Congress of Rehabilitation Medicine Diagnostic Criteria for Mild Traumatic Brain InjuryNoah D Silverberg, Grant L Iverson, , et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer typesDavid R Gandara, Neeraj Agarwal, Shilpa Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance MechanismsHanna Tukachinsky, Russell W Madison, Jon H Chung, et al.
The Journal of Molecular Diagnostics : JMD|August 22, 2025
High-Specificity Detection of UV Mutational Signatures in Circulating Tumor DNA for Diagnostic Classification of Cutaneous and Unknown Primary Tumors Using FoundationOne Liquid CDxDouglas A Mata, Angela A Kou, Andreas M Heilmann, et al.
Oncotarget|July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerKarim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted TherapiesM Aldea, S Lenahan, M-A Locquet, et al.
Archives of Physical Medicine and Rehabilitation|May 21, 2023
The American Congress of Rehabilitation Medicine Diagnostic Criteria for Mild Traumatic Brain InjuryNoah D Silverberg, Grant L Iverson, , et al.
Pageof 25